1. Fusariosis in Mexico: A 10-year retrospective series.
- Author
-
Barragán-Reyes A, Jácome LEL, Perales-Martínez D, Nava-Ruiz A, Hernández MLG, Cornejo-Juárez P, Rincón-Zuno J, Camacho A, Cendejas RF, Guzmán JMF, Rivera-Martínez NE, Ontañón-Zurita D, Reséndiz-Sánchez J, Juárez-Hernández E, and Aguilar-Zapata D
- Subjects
- Humans, Amphotericin B therapeutic use, Antifungal Agents therapeutic use, Retrospective Studies, Mexico epidemiology, Voriconazole therapeutic use, Fusariosis drug therapy, Fusariosis epidemiology, Fusariosis veterinary, Fusarium, Hematologic Neoplasms veterinary, Burns complications, Burns epidemiology, Burns veterinary, Febrile Neutropenia drug therapy, Febrile Neutropenia veterinary
- Abstract
Fusarium species represent an opportunistic fungal pathogen. The data in Mexico about Fusarium infections in humans are scarce. Here, we present a retrospective series of patients with a confirmed diagnosis of fusariosis in eight different hospitals in Mexico from January 2010 to December 2019. The diagnosis of proven fusariosis was made according to the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORT/MSG) criteria. A total of 49 cases were identified in our series. Most patients had burn injuries (49%), and 37% had hematological malignancies. Most patients had fire injuries (40%), followed by electric injuries (8%), febrile neutropenia (10%), and pancytopenia (6%). Patients had skin and soft tissue involvement in 49%, followed by blood culture isolation and biopsies from different sites of the body (lung, sinuses, bone tissue, and eyes). Febrile neutropenia (10%) and fungemia (8%) were the most common clinical syndromes in immunosuppressed patients. Most patients received monotherapy (67%), where voriconazole was used in 30% of the cases, followed by conventional amphotericin B (16%), and lipidic formulations of amphotericin B in 10% (either liposomal amphotericin B or amphotericin B lipid complex). Combination therapy was used in 20% of the cases, and the most common combination therapy was triazole plus any lipidic formulation of amphotericin B (10%). Mortality related to Fusarium infection occurred in 22% of patients. Fusariosis is a serious threat. Burn injuries and hematologic malignancies represent the most common causes of infection in this small series from Mexico., (© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2023
- Full Text
- View/download PDF